Recent Updates
Recently added Catalysts

Overdenture Treatment

Phase 2

Dental Implantation | Unknown | ENT |Envista Holdings Corporation|Last Updated: Feb 22, 2012

Success Probability
Subscribe to view
Market & Valuation
Subscribe to view
Trial Design
RandomizedACTIVE_CONTROLLEDDMCBiomarker
Total Trials1
Total Enrollment30
FDA Designations
No designations recorded
Clinical trial landscape

Overdenture Treatment · 1 trial · 1 indication

Phase 2 1
NCT00066014Clinical Investigation of Mandibular Implant OverdentureDental Implantation
COMPLETED30 Analytics
PHASE2COMPLETED
Clinical Investigation of Mandibular Implant Overdenture
Dental Implantation
NCT0006601430
Unlock trial analytics
Study Endpoints
Primary Endpoints
Comparison of implant overdenture clinical modalities using clinical measures to compare treatment outcomes
6 month and 12 month
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
treatment modalities changed for comparisonACTIVE_COMPARATORAll subjects experienced all treatment modalities being studied.
Interventions
NameTypeDescription
Implant Overdenture TreatmentPROCEDUREAll overdenture treatment modalities were provided to each subject using a crossover design.
Unlock Study Design Details
Eligibility Criteria
Age Range21 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion: * Adult patient; * Male or female; * At least one year of previous conventional complete denture treatment history; * Willing to accept the conditions of the study and informed consent freely given; * Ability to participate for 6 years; * Able to understand and respond to self-reporting ...

Countries:United States
Unlock Eligibility Criteria